Richard Buchholz Sells 4,000 Shares of Inspire Medical Systems (NASDAQ:INSP) Stock

Share on StockTwits

Inspire Medical Systems (NASDAQ:INSP) CFO Richard Buchholz sold 4,000 shares of the stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $68.34, for a total value of $273,360.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Richard Buchholz also recently made the following trade(s):

  • On Monday, June 17th, Richard Buchholz sold 4,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $56.37, for a total value of $225,480.00.
  • On Monday, May 20th, Richard Buchholz sold 4,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $50.05, for a total value of $200,200.00.

Shares of INSP opened at $68.03 on Friday. Inspire Medical Systems has a 52 week low of $35.43 and a 52 week high of $69.71. The firm has a fifty day moving average price of $60.37.

Inspire Medical Systems (NASDAQ:INSP) last announced its earnings results on Tuesday, May 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.39) by $0.04. The company had revenue of $16.30 million for the quarter, compared to the consensus estimate of $17.79 million. The firm’s quarterly revenue was up 63.0% on a year-over-year basis.

INSP has been the subject of a number of research reports. Zacks Investment Research upgraded Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 price target for the company in a research note on Saturday, July 13th. Bank of America reiterated a “sell” rating on shares of Deutsche Bank in a research note on Monday, July 8th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $57.20.

A number of large investors have recently made changes to their positions in INSP. William Blair Investment Management LLC raised its position in Inspire Medical Systems by 416.4% during the 1st quarter. William Blair Investment Management LLC now owns 1,096,095 shares of the company’s stock worth $62,236,000 after purchasing an additional 883,826 shares during the last quarter. BlackRock Inc. raised its position in Inspire Medical Systems by 47.5% during the 4th quarter. BlackRock Inc. now owns 805,471 shares of the company’s stock worth $34,031,000 after purchasing an additional 259,453 shares during the last quarter. OppenheimerFunds Inc. raised its position in Inspire Medical Systems by 91.1% during the 1st quarter. OppenheimerFunds Inc. now owns 528,999 shares of the company’s stock worth $30,037,000 after purchasing an additional 252,178 shares during the last quarter. Millennium Management LLC raised its position in Inspire Medical Systems by 326.5% during the 4th quarter. Millennium Management LLC now owns 273,079 shares of the company’s stock worth $11,538,000 after purchasing an additional 209,048 shares during the last quarter. Finally, Columbus Circle Investors raised its position in Inspire Medical Systems by 396.0% during the 1st quarter. Columbus Circle Investors now owns 233,754 shares of the company’s stock worth $13,273,000 after purchasing an additional 186,627 shares during the last quarter.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Read More: Beige Book

Insider Buying and Selling by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Continental Resources, Inc.  Given Consensus Recommendation of “Buy” by Brokerages
Continental Resources, Inc. Given Consensus Recommendation of “Buy” by Brokerages
Bruker Co.  Receives $49.20 Consensus Price Target from Analysts
Bruker Co. Receives $49.20 Consensus Price Target from Analysts
Rio Tinto plc ADR  Receives Average Rating of “Hold” from Brokerages
Rio Tinto plc ADR Receives Average Rating of “Hold” from Brokerages
Crescent Point Energy Corp  Receives Average Recommendation of “Buy” from Analysts
Crescent Point Energy Corp Receives Average Recommendation of “Buy” from Analysts
Eastgroup Properties Inc  Given Consensus Recommendation of “Hold” by Brokerages
Eastgroup Properties Inc Given Consensus Recommendation of “Hold” by Brokerages
Brokerages Set Canadian National Railway  Price Target at C$125.09
Brokerages Set Canadian National Railway Price Target at C$125.09


© 2006-2019 Ticker Report